Key result
Specific bradycardic agents, which inhibit the funny current in sinus node pacemaker cells, may prove to be ideal therapies for the management of sinus tachyarrhythmias.
Why the study?
Do specific bradycardic agents improve the management of sinus tachyarrhythmias?
Do specific bradycardic agents improve the management of sinus tachyarrhythmias?
This review highlights the potential of specific bradycardic agents (funny current inhibitors) as targeted therapies for managing various sinus tachyarrhythmias.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice; hypothesis-generating for funny current inhibitors and requires prospective trials.
Yusuf et al. (2003) conducted a review in Sinus tachyarrhythmias. Specific bradycardic agents was evaluated. Specific bradycardic agents, which inhibit the funny current in sinus node pacemaker cells, may prove to be ideal therapies for the management of sinus tachyarrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: